Average Co-Inventor Count = 3.05
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novo Nordisk A/s (17 from 1,777 patents)
2. A/s Ferrosan (7 from 41 patents)
3. Schering Aktiengesellschaft (5 from 1,384 patents)
4. Contera Pharma Aps (3 from 3 patents)
5. Contera Pharma A/s (2 from 2 patents)
6. Conrig Pharma Aps (2 from 2 patents)
7. Other (1 from 832,843 patents)
8. Novo Nordiskals (1 from 10 patents)
9. Solural Pharma Aps (1 from 3 patents)
10. Novo Nordisk Ais (1 from 1 patent)
11. Novo Nordisk N/a (1 from 1 patent)
40 patents:
1. 11975104 - Pulsatile drug delivery system for treating morning akinesia
2. 11819482 - Composition comprising suplatast tosilate
3. 11690814 - Suplatast tosilate for use in the treatment of cough associated with interstitial lung disease
4. 11478476 - Use of buspirone metabolites
5. 10632116 - Combinations of serotonin receptor agonists for treatment of movement disorders
6. 10561618 - Orally available pharmaceutical formulation suitable for improved management of movement disorders
7. 9186359 - Combinations of serotonin receptor agonists for treatment of movement disorders
8. 6410743 - Tetrahydronaphtalene derivatives and their use
9. 6365609 - Substituted 3,3-diamino-2-propenenitriles, their preparation and use
10. 6362205 - Substituted 3,3-diamino-2-propenenitriles, their preparation and use
11. 6329367 - Fused 1,2,4-thiadiazine derivatives, their preparation and use
12. 6242443 - 1,2,4-benzothiadiazine derivatives, their preparation and use
13. 6232310 - Fused 1,4-thiazine-2-carbonitrile derivatives, their preparation and use
14. 6225310 - Fused 1,2,4-thiadiazine derivatives, their preparation and use
15. 6147098 - Substituted guanidines and diaminonitroethenes, their preparation and use